West Pharmaceutical signals 10%-11% 2026 organic revenue growth and $8.85-$9.05 adjusted EPS amid leadership transition

EarningsPositive

AI Analysis

Summary

West Pharmaceutical provided 2026 guidance projecting 10%-11% organic revenue growth and adjusted EPS of $8.85-$9.05, concurrent with a leadership transition announcement.

Financial Highlights

Revenue

10%-11% organic growth expected in 2026

EPS

$8.85-$9.05 adjusted EPS

Guidance

2026 guidance provided: 10%-11% organic revenue growth and $8.85-$9.05 adjusted EPS

Importance:5/10

Sentiment:

0.50

guidanceleadership transition2026 outlookearnings

Related Companies

$WST

Read the original article

Published by Seeking Alpha Healthcare on July 23, 2026 3:42 PM

Read Original